Privia Health Group, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Privia Health Group, Inc. (PRVA) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $9.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-06
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $9.73M, a 196.05% increase year-over-year.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $3.71M, a 38.64% decline year-over-year.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $10.59M, a 97.22% increase year-over-year.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $9.81M, a 146.53% increase year-over-year.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was $29.73M, a 74.41% increase from fiscal 2024.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was $17.04M, a 18.95% decline from fiscal 2023.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was $21.03M.
- Privia Health Group, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$12.06M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.73M 10-Q · filed 2026-08-06 | $13.44M 10-Q · filed 2026-08-06 | $24.03M derived: sum of 3 quarters · filed 2026-08-06 | $33.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.71M 10-Q · filed 2026-08-06 | $14.29M derived: sum of 2 quarters · filed 2026-08-06 | $24.10M derived: sum of 3 quarters · filed 2026-08-06 | $27.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $10.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $20.39M derived: sum of 2 quarters · filed 2026-02-27 | $23.68M derived: sum of 3 quarters · filed 2026-08-06 | $29.73M 10-K · filed 2026-02-27 |
| 2025-09-30 | $9.81M 10-Q · filed 2025-11-06 | $13.10M derived: sum of 2 quarters · filed 2026-08-06 | $19.14M 10-Q · filed 2025-11-06 | $24.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.29M 10-Q · filed 2026-08-06 | $9.33M 10-Q · filed 2026-08-06 | $14.70M derived: sum of 3 quarters · filed 2026-08-06 | $18.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $6.05M 10-Q · filed 2026-08-06 | $11.41M derived: sum of 2 quarters · filed 2026-08-06 | $15.39M derived: sum of 3 quarters · filed 2026-08-06 | $20.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.35M derived: sum of 2 quarters · filed 2026-02-27 | $13.99M derived: sum of 3 quarters · filed 2026-02-27 | $17.04M 10-K · filed 2026-02-27 |
| 2024-09-30 | $3.98M 10-Q · filed 2025-11-06 | $8.62M derived: sum of 2 quarters · filed 2025-11-06 | $11.68M 10-Q · filed 2025-11-06 | $14.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $4.64M 10-Q · filed 2025-11-06 | $7.70M 10-Q · filed 2025-08-07 | $10.02M derived: sum of 3 quarters · filed 2026-02-27 | $15.96M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $3.06M 10-Q · filed 2025-11-06 | $5.38M derived: sum of 2 quarters · filed 2026-02-27 | $11.32M derived: sum of 3 quarters · filed 2026-02-27 | $17.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.27M derived: sum of 2 quarters · filed 2026-02-27 | $14.63M derived: sum of 3 quarters · filed 2026-02-27 | $21.03M 10-K · filed 2026-02-27 |
| 2023-09-30 | $5.94M 10-Q · filed 2024-11-07 | $12.30M derived: sum of 2 quarters · filed 2024-11-07 | $18.70M 10-Q · filed 2024-11-07 | $35.55M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $6.36M 10-Q · filed 2024-11-07 | $12.76M 10-Q · filed 2024-08-08 | $29.61M derived: sum of 3 quarters · filed 2025-02-27 | $30.17M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $6.40M 10-Q · filed 2024-11-07 | $23.25M derived: sum of 2 quarters · filed 2025-02-27 | $23.81M derived: sum of 3 quarters · filed 2025-02-27 | $12.43M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $17.40M derived: sum of 2 quarters · filed 2025-02-27 | $6.02M derived: sum of 3 quarters · filed 2025-02-27 | -$12.06M 10-K · filed 2025-02-27 |
| 2022-09-30 | $556.00K 10-Q · filed 2023-11-03 | -$10.82M derived: sum of 2 quarters · filed 2023-11-03 | -$28.91M 10-Q · filed 2023-11-03 | -$40.80M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$11.38M 10-Q · filed 2023-11-03 | -$29.47M 10-Q · filed 2023-08-03 | -$41.36M derived: sum of 3 quarters · filed 2024-02-27 | -$52.25M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$18.09M 10-Q · filed 2023-11-03 | -$29.98M derived: sum of 2 quarters · filed 2024-02-27 | -$40.87M derived: sum of 3 quarters · filed 2024-02-27 | -$214.35M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$11.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$22.78M derived: sum of 2 quarters · filed 2024-02-27 | -$196.26M derived: sum of 3 quarters · filed 2024-02-27 | -$190.65M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$10.89M 10-Q · filed 2022-11-10 | -$184.38M derived: sum of 2 quarters · filed 2022-11-10 | -$178.76M 10-Q · filed 2022-11-10 | -$174.98M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$173.49M 10-Q · filed 2022-11-10 | -$167.87M 10-Q · filed 2022-08-11 | -$164.09M derived: sum of 3 quarters · filed 2023-03-01 | -$147.49M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $5.62M 10-Q · filed 2022-11-10 | $9.39M derived: sum of 2 quarters · filed 2023-03-01 | $26.00M derived: sum of 3 quarters · filed 2023-03-01 | $31.19M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $20.38M derived: sum of 2 quarters · filed 2023-03-01 | $25.57M derived: sum of 3 quarters · filed 2023-03-01 | $30.90M 10-K · filed 2023-03-01 |
| 2020-09-30 | $16.60M 10-Q · filed 2021-11-08 | $21.80M derived: sum of 2 quarters · filed 2021-11-08 | $27.13M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $5.20M 10-Q · filed 2021-11-08 | $10.53M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $5.33M 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $7.95M 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |